Trial · NCT00705484
Adverse events1,611
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 1,611
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Colitis Ulcerative | Gastrointestinal disorders | Remicade Group | 213 | 1,059 | 314 |
| other | Colitis Ulcerative | Gastrointestinal disorders | Standard Therapy Group | 145 | 1,180 | 207 |
| other | Colitis Ulcerative | Gastrointestinal disorders | Switched to Remicade Group | 51 | 296 | 75 |
| other | Nasopharyngitis | Infections and infestations | Remicade Group | 64 | 1,059 | 79 |
| other | Nasopharyngitis | Infections and infestations | Standard Therapy Group | 23 | 1,180 | 25 |
| other | Nasopharyngitis | Infections and infestations | Switched to Remicade Group | 9 | 296 | 9 |
| other | Arthralgia | Musculoskeletal and connective tissue disorders | Remicade Group | 95 | 1,059 | 116 |
| other | Arthralgia | Musculoskeletal and connective tissue disorders | Standard Therapy Group | 24 | 1,180 | 28 |
| other | Arthralgia | Musculoskeletal and connective tissue disorders | Switched to Remicade Group | 17 | 296 | 20 |
| serious | Anaemia | Blood and lymphatic system disorders | Remicade Group | 6 | 1,059 | 6 |
| serious | Anaemia | Blood and lymphatic system disorders | Standard Therapy Group | 2 | 1,180 | 2 |
| serious | Anaemia | Blood and lymphatic system disorders | Switched to Remicade Group | 2 | 296 | 3 |
| serious | Bicytopenia | Blood and lymphatic system disorders | Remicade Group | 1 | 1,059 | 1 |
| serious | Bicytopenia | Blood and lymphatic system disorders | Standard Therapy Group | 0 | 1,180 | 0 |
| serious | Bicytopenia | Blood and lymphatic system disorders | Switched to Remicade Group | 0 | 296 | 0 |
| serious | Bone Marrow Failure | Blood and lymphatic system disorders | Remicade Group | 1 | 1,059 | 1 |
| serious | Bone Marrow Failure | Blood and lymphatic system disorders | Standard Therapy Group | 0 | 1,180 | 0 |
| serious | Bone Marrow Failure | Blood and lymphatic system disorders | Switched to Remicade Group | 0 | 296 | 0 |
| serious | Haemolytic Anaemia | Blood and lymphatic system disorders | Remicade Group | 2 | 1,059 | 2 |
| serious | Haemolytic Anaemia | Blood and lymphatic system disorders | Standard Therapy Group | 0 | 1,180 | 0 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00705484/events